Skip to main content
Log in

Complement deficiency states and meningococcal disease

  • The Year in Complement
  • Published:
Immunologic Research Aims and scope Submit manuscript

Abstract

Analysis of complement deficiency states has supported the role of complement in host defense and elucidated diseases associated with defective complement function. Although neisserial infection plays a prominent role in these deficiency states, examination of individuals with late complement component deficiency (LCCD) reveals a particular propensity for recurrent meningococcal disease and provides important clues to the role of complement in neisserial infections. In response to meningococcal disease, LCCD individuals produce significantly greater amounts of antilipooligosaccharide (LOS) antibody which can kill group B meningococcus in a complement-sufficient in vitro system. Further studies of antibody cross-reactivity to other meningococci has led to a clearer understanding of its epitopic specificity. Nevertheless, epidemiologic evidence is consistent with the relative absence of protective immunity in LCCD persons following an episode of infection and supported by quantitation of antibody to capsular polysaccharide. However, compared to anti-LOS antibodies, anticapsular antibodies can offer immune protection to LCCD individuals via complement-dependent opsonophagocytosis-the only form of complement-mediated killing available to these persons. Thus vaccination of LCCD persons with capsular antigens is considered an important means of protecting these high-risk individuals against meningococcal disease.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Ross GD: Introduction and history of complement research; in Ross GD (ed): Immunobiology of the Complement System. Orlando, Academic Press, 1986, pp 1–20.

    Google Scholar 

  2. Ross SC, Densen P: Complement deficiency states and infection: Epidemiology pathogenesis and consequences of Neisseria and other infections in an immune deficiency. Medicine (Baltimore) 1984;63:243–273.

    CAS  Google Scholar 

  3. Figueroa JE, Densen P: Infectious diseases associated with complement deficiencles. Clin Microbiol Rev 1991;4:359–395.

    PubMed  CAS  Google Scholar 

  4. Sjöholm AG: Innerited compiement deficiency states: Implications for immunity and immunological disease. Acta Pathol Microbiol Immunol Scand (C) 1990;98:861–874.

    Google Scholar 

  5. Alper CA, Awdeh Z, Yunis EJ: Frequency of the C2 deficiency gene among normal Caucasians (abstract). Complement 1987;4:125.

    Google Scholar 

  6. Nagata M, Hara T, Aoki T, Mizuno Y, Akeda H, Inaba S, Tsumoto K, Ueda K: Inherited deficiency of ninth component of complement: An increased risk of meningococcal meningitis. J Pediatr 1989;114:260–264.

    Article  PubMed  CAS  Google Scholar 

  7. Rasmussen JM, Teisner B, Weihe P, Mathiassen B, Petersen T, Isager H: Screening for complement deficiencies in patients surviving from epidemic meningococcal disease. J Clin Lab Immunol 1988;25:161–165.

    PubMed  CAS  Google Scholar 

  8. Weihe P, Mathiassen B, Rasmussen JM, Petersen T, Isager H: An epidemic outbreak of group B meningococcal disease on the Faroe Islands. Scand J Infect Dis 1988;20: 291–296.

    Article  PubMed  CAS  Google Scholar 

  9. Rogde S, Holiby EA, Teisberg P, Olaisen B: Genetic aspects of complement component C8 in Norwegian meningococcal disease patients. Scand J Infect Dis 1990;22: 673–679.

    Article  PubMed  CAS  Google Scholar 

  10. Belodorodov VB, Platonov AE: Meningococcal disease in the USSR in patients with deficiencies in rate complement components; in Achtman M, Kohl P, Marchal C, Morelli G, Seiler A, Thiesen B (eds): Neisseriae 1990, Berlin, de Gruyter & Co, 1991, pp 659–663.

    Google Scholar 

  11. Glass D, Raum D, Gibson D, Stillman JS, Schur PH: Inherited deficiency of the second component of complement. Rheumatic disease association. J Clin Invest 1976;58:853.

    Article  PubMed  CAS  Google Scholar 

  12. Densen P, Sanford M, Burke T, Densen E, Wintermeyer L: Prospective study of the prevalence of complement deficiency in meningitis. (abstract). Program Abstr 30th Intersci Congr Antimicrob Agents, Am Soc Microbiol, Washington, D.C., 1990, p. 140.

  13. Böttger, EC, Bitter-Suermann D: Complement and the regulation of humoral immune responses. Immunol Today 1987;8;261–264.

    Article  Google Scholar 

  14. Ochs, HD, Wedgwood RJ, Frank MM, Heiler SR, Hosea SW: The role of complement in the induction of antibody responses. Clin Exp Immunol 1983;53:208–216.

    PubMed  CAS  Google Scholar 

  15. Ochs HD, Wedgwood RJ, Heller SR, Beatty PG: Complement, membrane glycoproteins, and complement receptors: Their role in regulation of the immune response. Clin Immunol Immunopathol 1986;40:94–104.

    Article  PubMed  CAS  Google Scholar 

  16. O'Neil KM, Ochs HD, Heller SR, Cork LC, Morris JM, Winkelstein JA: Role of C3 in humoral immunity: Defective antibody production in C3-deficient dogs. J Immunol 1988; 140:1939–1945.

    PubMed  Google Scholar 

  17. Densen P, Mandell GL: Granulocytic phagocytes; in Mandell GL, Douglas RG Jr, Bennett JE (eds): Principles and Practice of Infectious Diseases. New York, Churchill Livingstone, 1990, pp 81–101.

    Google Scholar 

  18. Fearon DT, Austen KF: Properdin: Initiation of the alternative complement pathway. Proc Natl Acad Sci USA 1975;72:3220–3224.

    Article  PubMed  CAS  Google Scholar 

  19. Fearon DT, Austen KF: Properdin: Binding to C3b and stabilization of the C3b-dependent C3 convertase. J Exp Med 1975;142:856–863.

    Article  PubMed  CAS  Google Scholar 

  20. Fearon DT, Austen KF: Current concepts in immunology: The alternative pathway of complement—A system for host resistance to microbial infection. N Engi J Med 1980; 303:259–263.

    CAS  Google Scholar 

  21. Pangburn MK: The alternative pathway; in Ross GD (ed). Immunobiology of the complement system. Orlando, Academic Press, 1986, pp 45–62.

    Google Scholar 

  22. Parra G, Takekoshi Y, Striegel J, Vernier RL, Michael AF: Acute serum sickness in normal and C6 deficient rabbits: Role of membrane attack complex. Int J Exp Pathol 1992;73:299–312.

    PubMed  CAS  Google Scholar 

  23. Cybulsky AV, Rennke HG, Feintzeig ID Salant DJ: Complementinduced glomerular epithelial cell injury: Role of the membrane attack complex in rat membranous nephropathy. J Clin Invest 1986;77: 1096–1107.

    Article  PubMed  CAS  Google Scholar 

  24. Halstensen TS, Mollnes TE, Fausa O, Brandtzaeg P: Deposits of terminal complement complex (TCC) in muscularis mucosac and submucosal vessels in ulcerative colitis and Crohn's disease of the colon. Gut 1989;30:361–366.

    Article  PubMed  CAS  Google Scholar 

  25. Rus HG, Niculescu F, Vlaicu R: Presence of C5b-9 complement complex and S-protein in human myocardial areas with necrosis and scierosis. Immunol Lett 1987;16:15–20.

    Article  PubMed  CAS  Google Scholar 

  26. Rus HG, Niculescu F, Constantinescu E, Cristea A, Vlaicu R: Immunoelectron-microscopic localization of the terminal C5b-9 complement complex in human atherosclerotic fibrous plaque. Atherosclerosis 1993;61:35–42.

    Article  Google Scholar 

  27. Harriman GR, Esser AF, Podack ER, Wunderlich AC, Braude AI, Lint TF, Curd JG: The role of C9 in complement-mediated killing of Neisseria. J Immunol 1981;127: 2386–2390.

    PubMed  CAS  Google Scholar 

  28. Ross SC, Berberich HM, Densen P: Natural serum bactericidal activity againstNeisseria meningitidis isclates from disseminated infections in normal and complement-deficient hosts. J Infect Dis 1985;152:1332–1335.

    PubMed  CAS  Google Scholar 

  29. Fijen CA, Kuijper EJ, Hannema AJ, Sjöholm AG, van Putten JP: Complement deficiencies in patients over ten years old with meningococcal disease due to uncommon serogroups. Lancet 1989;ii:585–588.

    Article  Google Scholar 

  30. Anonymous: Analysis of endemic meningococcal disease by serogroup and evaluation of chemoprophylaxis. J Infect Dis 1976;134:201–204.

    Google Scholar 

  31. Ross SC, Rosenthal J, Berberich HM, Densen P: Kiding ofNeisseria meningitidis by human neutrophils: Implications for normal and complement-deficient individuals. J Infect Dis 1987;155:1266–1275.

    PubMed  CAS  Google Scholar 

  32. Wenger JD, Hightower AW, Facklam RR, Gaventa S, Broome CV: Bacterial meningitis in the United States, 1986: Report of a multistate surveillance study. J Infect Dis 1990;162:1316–1323.

    PubMed  CAS  Google Scholar 

  33. Brandtzaeg P, Joø GB, Brusletto B, Kierulf P: Piasminogen activator inhibitor 1 and 2, alpha-2-antiplasmin, plasminogen, and endotoxin levels in systemic meningococcaldisease. Thromb Res 1990;57:271–278.

    Article  PubMed  CAS  Google Scholar 

  34. Brandtzaeg P, Kierulf P, Gaustad P, Skulberg A, Bruun JN, Halvorsen S, Sörensen E: Plasma endotoxin as a predictor of multiple organ failure and death in systemic meningococcal disease. J Infect Dis 1989;159: 195–204.

    PubMed  CAS  Google Scholar 

  35. Brandtzaeg P, Mollnes TE, Kierulf P: Complement activation and endotoxin levels in systemic meningococcal disease. J Infect Dis 1989; 160:58–65.

    PubMed  CAS  Google Scholar 

  36. Brandtzaeg P, Sandset PM, Joø GB, Ovstebø R, Abildgaard U, Kierulf P: The quantitative association of plasma endotoxin, antithrombin, protein C, extrinsic pathway inhibitor and fibrinopeptide A in systemic meningococcal disease. Thromb Res 1989;55:459–470.

    Article  PubMed  CAS  Google Scholar 

  37. Waage A, Brandtzaeg P, Halstensen A, Kierulf P, Espevik T: The complex pattern of cytokines in serum from patients with meningococcal septic shock: Association between interleukin 6, interleukin 1, and fatal outcome. J Exp Med 1989;169:333–338.

    Article  PubMed  CAS  Google Scholar 

  38. Zwahlen A, Waldvogel FA: Magnitude of bacteremia and complement activation duringNeisseria meningitidis infection: Study of two co-primary cases with different clinical presentations. Eur J Clin Microbiol 1984;3:439–441.

    Article  PubMed  CAS  Google Scholar 

  39. Platonov AE, Beloborodov VB Late complement component deficiency (LCCD) in the USSR: The situation in 1991 (abstract). Complement Inflamm 1991;8:211.

    Google Scholar 

  40. Brown DL, Lachmann PJ: The behaviour of complement and platelets in lethal endotoxin shock in rabbits. Int Arch Allergy 1973;45:193–205.

    CAS  Google Scholar 

  41. Hänsch GM, Seitz M, Martinotti G, Betz M, Rauterberg EW, Gemsa D: Macrophages release arachidonic acid, prostaglandins E2, and thromboxane in response to late complement components. J Immunol 1984; 133:2145–2150.

    PubMed  Google Scholar 

  42. Imagawa DK, Osifchin NE, Paznekas WA, Shin ML, Mayer MM: Consequences of cell membrane attack by complement: Release of arachidonate and formation of inflammatory derivatives. Proc Natl Acad Sci USA 1983;80:6647–6651.

    Article  PubMed  CAS  Google Scholar 

  43. Hamilton KK, Hattori R, Esmon CT, Sims PJ: Complement proteins C5b-9 induce vesiculation of the endothelial plasma membrane and expose catalytic surface for assembly of the prothrombinase enzyme complex. J Biol Chem 1990;265:3809–3814.

    PubMed  CAS  Google Scholar 

  44. Sims PJ, Wiedmer T: The response of human platelets to activated components of the complement system. Immunol Today 1991;12:338–342.

    Article  PubMed  CAS  Google Scholar 

  45. Goldschneider I, Gotschlich EC, Artenstein MS: Human immunity to the meningococcus. I. The role of humoral antibodies. J Exp Med 1969;129:1307–1326.

    Article  PubMed  CAS  Google Scholar 

  46. Goldschneider I, Gotschlich EC, Artenstein MS: Human immunity to the meningococcus. II. Development of natural immunity J Exp Med 1969;129:1327–1348.

    Article  PubMed  CAS  Google Scholar 

  47. Roberts RB: The relationship between group A and group C meningococcal polysaccharides and serum opsonins in man. J Exp Med 1970; 131:499–513.

    Article  PubMed  CAS  Google Scholar 

  48. Andreoni J, Käyhty H, Densen P: Vaccination and the role of capsular polysaccharide antibody in prevention of recurrent meningococcal disease in late complement component deficient individuals J Infect Dis 1993;168:227–231.

    PubMed  CAS  Google Scholar 

  49. Brown EJ, Joiner KA, Cole RM, Berger M: Localization of complement component 3 onStreptococcus pneumoniae: Anti-capsular antibody causes complement deposition on the pneumococcal capsule. Infect Immun 1983;39:403–409.

    PubMed  CAS  Google Scholar 

  50. Wilkinson BJ, Sisson SP, Kim Y, Peterson PK: Localization of the third component of complement on the cell wall of encapsulated,Staphylococcus aureus M: Implications for the mechanism of resistance to phagocytosis. Infect Immun 1979; 26:1159–1163.

    PubMed  CAS  Google Scholar 

  51. Orren A, Warren RE, Potter PC, Jones AM, Lachmann PJ, Poolman JT: Antibodies to meningococcal class 1 outer membrane proteins in South African complement-deficient and complement-sufficient subjects. Infect Immun 1992;60: 4510–4516.

    PubMed  CAS  Google Scholar 

  52. Orren A, Potter PC, Cooper RC, du Toit E: Deficiency of the sixth component of complement and susceptibility toNeisseria meningitidis infections: Studies in 10 families and five isolated cases. Immunology 1987;62:249–253.

    PubMed  CAS  Google Scholar 

  53. Steuer KLK, Sloan LB, Oglesby TJ, Farries TC, Nickells MW, Densen P, Harley JB, Atkinson JP: Lysis of sensitized sheep erythrocytes in human sera deficient in the second component of complement. J Immunol 1989;143:2256–2361.

    CAS  Google Scholar 

  54. Densen P, Weiler JM, Griffiss JM, Hoffman LG: Familial properdin deficiency and fatal meningococcemia: Correction of the bactericidal defect by vaccination. N Engl J Med 1987;316:922–926.

    PubMed  CAS  Google Scholar 

  55. Söderstrom C, Braconier JH, Danielsson D, Sjöholm AG, Thuresson B: Immune response to tetravalent meningococcal vaccine: Opsonic and bactericidal functions of normal and properdin deficient sera. Eur J Clin Microbiol Infect Dis 1989;8:220–224.

    Article  PubMed  Google Scholar 

  56. Potter PC, Frasch CE, van der Sande WJ, Cooper RC, Patel Y, Orren A: Prophylaxis againstNeisseria meningitidis infections and antibody responses in patients with deficiency of the sixth component of complement. J Infect Dis 1990;161:932–937.

    PubMed  CAS  Google Scholar 

  57. Densen P, Brown EJ, O'Neill GJ, Tedesco F, Clark RA, Frank MM, Webb D, Myers J: Inherited deficiency of C8 in a patient with recurrent meningococcal infections: Further evidence for a dysfunctional C8 molecule and nonlinkage to the HLA system. J Clin Immunol 1983; 3:90–99.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Figueroa, J., Andreoni, J. & Densen, P. Complement deficiency states and meningococcal disease. Immunol Res 12, 295–311 (1993). https://doi.org/10.1007/BF02918259

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF02918259

Key Words

Navigation